임상 추론: 삼킴장애로 내원한 52세 여자

참고문헌 (13)

1. Cook IJ, "Oropharyngeal dysphagia", Gastroenterol Clin North Am, 38, pp.411~431 (2009)
2. Cook IJ, "AGA technical review on management of oropharyngeal dysphagia", Gastroenterology, 116, pp.455~478 (1999)
3. 박진모, "리툭시맙치료 후 완화에 도달한 난치성중증근무력증환자", 대한신경과학회지, 35(1), pp.26~29 (2017), 대한신경과학회[DOI]
4. Rodolico C, "MuSK-associated myasthenia gravis: clinical features and management", Front Neurol, 11, pp.660~ (2020)
5. Evoli A, "Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis", Brain, 126, pp.2304~2311 (2003)
6. Deymeer F, "Clinical comparison of anti-MuSK- vs anti-AChR- positive and seronegative myasthenia gravis", Neurology, 68, pp.609~611 (2007)
7. Clifford KM, "Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis", Muscle Nerve, 59, pp.404~410 (2019)
8. Nikolic A, "Electrophysiological profile of the patients with MuSK positive myasthenia gravis", Neurol Res, 36, pp.945~949 (2014)
9. Gilhus NE, "Myasthneia gravis", New Engl J Med, 375, pp.2570~2581 (2016)
10. Sanders DB, "Clinical aspects of MuSK antibody positive seronegative MG", Neurology, 60, pp.1978~1980 (2003)
11. Evoli A, "3,4-diaminopyridine may improve myasthenia gravis with MuSK antibodies", Neurology, 86, pp.1070~1701 (2016)
12. Hehir MK, "Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review", Neurology, 89, pp.1069~1077 (2017)
13. Sanders DB, "International consensus guidance for management of myasthenia gravis: executive summary", Neurology, 87, pp.4419~4425 (2016)

관련 논문AI추천